Emerging & Re-Emerging

 

 

The Ebola & Zika outbreaks brought emerging and re-emerging diseases screaming into the limelight. This brought with it a renewed vigor for vaccines from the public and a catalyst for the scientific community to progress vaccines for diseases such as Ebola, Malaria, Dengue, and Chikungunya. Use this Conference to meet with and demonstrate your knowledge to the organizations who are pushing forward in this area.

 

Who Attends

 

• Pharma
• Biotech
• National and International Government
• Non-Profit Organizations
• Academics And Research Institutions

 

Job Titles

 

• CEO / CSO / COO
• CMO / Head of Scientific Affairs
• Head of Infectious / Emerging / Neglected Disease
• Head of R&D
• Head of Virology
• Head of Immunology

Who Should Sponsor?

 

• Platform Technology Providers
• Logistics / Cold Chain
• Biotechs
• Big Pharma

 

 

Emerging and Re-emerging Diseases, Tuesday 16 April 2019

Emerging and Re-emerging Diseases
09:00

Chair's opening remarks

Ebola & Flavivirus Update

Emerging and Re-emerging Diseases
09:55

Zika vaccine update

Nelson Michael
Emerging and Re-emerging Diseases
10:10

Executing multi-international trials and research for infectious diseases at WRAIR

10:40

Networking Coffee Break

Global Health Preparedness Strategy and Platform Technologies

Wolfgang Bender
Emerging and Re-emerging Diseases
11:40

Targeting a single-shot vaccine against Chikungunya: VLA 1553 Phase 1 initial results and development outlook

Emerging and Re-emerging Diseases
12:10

Progress made from CEPI collaborations for a Nipah vaccine

Senior representative, Nipah Project Leader, PATH
Emerging and Re-emerging Diseases
12:25

Applying knowledge from HIV to develop a Lassa vaccine

Rerserved for IAVI
Dr Max Søgaard
Emerging and Re-emerging Diseases
12:55

ExpreS2 – An insect cell-based vaccine production system suitable for difficult-to-express proteins

13:10

Networking Lunch & Poster Session

Intervention Trials for Aedes-Transmitted Diseases

Thomas Lingelbach
Emerging and Re-emerging Diseases
14:40

Towards a novel prophylactic vaccine for the prevention of Lyme disease: Development status and outlook

16:09

Networking Coffee Break

Nick Hamon
Emerging and Re-emerging Diseases
16:40

The global vector control response: The issue of integrating vaccine with vector control with a focus on new VC technology

  • Where are we on dengue, malaria, chikungunya, yellow fever and Zika
  • How can vaccines and vector control be integrated and used synergistically and has it worked?
John Barry
Emerging and Re-emerging Diseases
17:40

How to achieve executional success in emerging/re-emerging disease studies with real world examples – The success formula

Emerging and Re-emerging Diseases
17:55

A Plug-and-Play technology platform to expedite the production of vaccines for biodefense and emerging infectious diseases

18:10

Chair’s Closing Remarks per co-lo and Close of Congress Day 2

18:15

Off-site Networking Drinks, follow the congress team

last published: 14/Dec/18 13:15

 

Emerging and Re-emerging Diseases, Wednesday 17 April 2019

Emerging and Re-emerging Diseases
09:00

Chair's opening remarks

Eliminating Global Infectious Diseases

Emerging and Re-emerging Diseases
09:10

What the gates MRI are doing: TB, malaria, enteric

David Sack
Emerging and Re-emerging Diseases
09:40

Use of oral cholera vaccine as a key component to eliminate epidemic cholera as a public health threat

Carl Dieffenbach
Emerging and Re-emerging Diseases
10:10

The path to controlling the Global HIV pandemic; the roles of antiretrovirals and preventive vaccines

10:40

Networking Coffee Break

12:30

Networking Lunch & Poster Session

DAY 3 AFTERNOON PLENARY OF CONGRESS: RENAISSANCE BALLROOM

Paul Offit
Dr Saad Omer
14:55

A framework for a comprehensive maternal immunization platform

  • Evidence for current immunization recommendations
  • Maternal vaccines in development
  • The need for evidence-based interventions at the practice, provider, and patient levels to ensure higher vaccination levels
Dr Timothy Cooke
16:00

Chair Closing Remarks and End of Congress

last published: 14/Dec/18 13:15

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071